Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Calandra

Showing results (51-60 of 99) with videos related to

Pageof 10
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 1, 1994
Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factorsP Y Bochud, P Eggiman, T Calandra, et al.
Journal of Clinical Microbiology|August 20, 2010
Multiplex blood PCR in combination with blood cultures for improvement of microbiological documentation of infection in febrile neutropeniaF Lamoth, K Jaton, G Prod'hom, et al.
The Journal of Infection|May 22, 2014
Mandatory infectious diseases consultation for MRSA bacteremia is associated with reduced mortalityF Tissot, T Calandra, G Prod'hom, et al.
The Journal of Infectious Diseases|March 1, 1995
Increased circulating soluble CD14 is associated with high mortality in gram-negative septic shockR Landmann, W Zimmerli, S Sansano, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1991
Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lymphomas and solid tumors. The European Organization for Research on Treatment of Cancer International Antimicrobial Therapy Cooperative GroupF Meunier, S H Zinner, H Gaya, et al.
Critical Care Medicine|July 11, 2001
Clinical expert round table discussion (session 1) at the Margaux Conference on Critical Illness: innate immunity: host recognition of and sensitivity to bacterial componentsH R Redl, A Aderem, B A Beutler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2001
Critical role of lipopolysaccharide-binding protein and CD14 in immune responses against gram-negative bacteriaD Le Roy, F Di Padova, Y Adachi, et al.
Thrombosis and Haemostasis|June 30, 1989
Plasminogen activator inhibitor 1: a new prognostic marker in septic shockG Pralong, T Calandra, M P Glauser, et al.
The Journal of Experimental Medicine|January 1, 1996
An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reactionJ Bernhagen, M Bacher, T Calandra, et al.
Infection and Immunity|December 19, 2000
Role of plasma, lipopolysaccharide-binding protein, and CD14 in response of mouse peritoneal exudate macrophages to endotoxinD Heumann, Y Adachi, D Le Roy, et al.
Pageof 10

Showing results (51-60 of 99) with videos related to

Sort By:
Pageof 10
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 1, 1994
Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factorsP Y Bochud, P Eggiman, T Calandra, et al.
Journal of Clinical Microbiology|August 20, 2010
Multiplex blood PCR in combination with blood cultures for improvement of microbiological documentation of infection in febrile neutropeniaF Lamoth, K Jaton, G Prod'hom, et al.
The Journal of Infection|May 22, 2014
Mandatory infectious diseases consultation for MRSA bacteremia is associated with reduced mortalityF Tissot, T Calandra, G Prod'hom, et al.
The Journal of Infectious Diseases|March 1, 1995
Increased circulating soluble CD14 is associated with high mortality in gram-negative septic shockR Landmann, W Zimmerli, S Sansano, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1991
Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lymphomas and solid tumors. The European Organization for Research on Treatment of Cancer International Antimicrobial Therapy Cooperative GroupF Meunier, S H Zinner, H Gaya, et al.
Critical Care Medicine|July 11, 2001
Clinical expert round table discussion (session 1) at the Margaux Conference on Critical Illness: innate immunity: host recognition of and sensitivity to bacterial componentsH R Redl, A Aderem, B A Beutler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2001
Critical role of lipopolysaccharide-binding protein and CD14 in immune responses against gram-negative bacteriaD Le Roy, F Di Padova, Y Adachi, et al.
Thrombosis and Haemostasis|June 30, 1989
Plasminogen activator inhibitor 1: a new prognostic marker in septic shockG Pralong, T Calandra, M P Glauser, et al.
The Journal of Experimental Medicine|January 1, 1996
An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reactionJ Bernhagen, M Bacher, T Calandra, et al.
Infection and Immunity|December 19, 2000
Role of plasma, lipopolysaccharide-binding protein, and CD14 in response of mouse peritoneal exudate macrophages to endotoxinD Heumann, Y Adachi, D Le Roy, et al.
Pageof 10